
    
      This is a prospective, four groups, open, comparative, controlled study. A total of 400
      completed, evaluated subjects will be enrolled in this study. Main Study Measures: Reactivity
      of T cells to selected SARS COV-2 peptides by MA test and IgG Antibody response to SARS COV-2
      by commercial ELISA test.

      Study Procedures:

        -  Screening

        -  Informed consent signing

        -  Medical history review

        -  Blood collection.

        -  MA test and ELISA test will be performed at Savicell's Laboratory site.
    
  